CRISPR Therapeutics AG
- Stock Issuer and Owners
CRISPR Therapeutics AG |
Ticker | CRSP |
CIK # | 0001674416 |
CUSIP | H17182108 |
Sector | Life Sciences - Biological Products, (No Disgnostic Substances) |
Address | Aeschenvorstadt 36, Basel, 4051 |
Source |
[EDGAR]
|
Form 13F Holdings |
Firm |
Period |
DFND |
Voting |
Shares |
ARK Investment Management LLC |
[2023-03-31]
|
SOLE |
7,304,293.0 |
7,990,188.0 |
Capital International Investors |
[2023-03-31]
|
DFND |
6,023,638.0 |
6,023,638.0 |
Sumitomo Mitsui Trust Holdings, Inc. |
[2023-03-31]
|
DFND |
3,973,180.0 |
3,973,180.0 |
Nikko Asset Management Americas Inc |
[2023-03-31]
|
SOLE |
3,604,564.0 |
3,972,139.0 |
T. Rowe Price Investment Management, Inc. |
[2023-03-31]
|
SOLE |
1,448,282.0 |
3,664,371.0 |
BlackRock Inc. |
[2023-03-31]
|
SOLE |
2,669,721.0 |
2,798,581.0 |
FMR LLC |
[2023-03-31]
|
DFND |
2,136,757.0 |
2,139,056.0 |
State Street Corp |
[2023-03-31]
|
DFND |
1,896,138.0 |
1,986,187.0 |
NEA Management Company LLC |
[2023-03-31]
|
DFND |
1,587,854.0 |
1,587,854.0 |
Vanguard Group Inc |
[2023-03-31]
|
SOLE |
0.0 |
1,392,430.0 |
Loomis Sayles & Co L P |
[2023-03-31]
|
DFND |
1,052,895.0 |
1,156,810.0 |
Price T Rowe Associates Inc /MD/ |
[2023-03-31]
|
SOLE |
223,949.0 |
1,081,903.0 |
Bellevue Group AG |
[2023-03-31]
|
DFND |
899,800.0 |
899,800.0 |
Credit Suisse AG |
[2023-03-31]
|
DFND |
827,208.0 |
847,273.0 |
Armistice Capital LLC |
[2023-03-31]
|
SOLE |
824,000.0 |
824,000.0 |
Geode Capital Management LLC |
[2023-03-31]
|
DFND |
809,984.0 |
809,984.0 |
Susquehanna International Group LLP |
[2023-03-31]
|
DFND |
296,789.0 |
759,789.0 |
Charles Schwab Investment Management Inc |
[2023-03-31]
|
SOLE |
640,777.0 |
640,777.0 |
Citadel Advisors LLC |
[2023-03-31]
|
DFND |
621,239.0 |
621,239.0 |
Dimensional Fund Advisors LP |
[2023-03-31]
|
SOLE |
585,508.0 |
594,682.0 |
JPMorgan Chase & Co |
[2023-03-31]
|
DFND |
480,551.0 |
575,953.0 |
Bank of America Corp /DE/ |
[2023-03-31]
|
DFND |
16,525.0 |
517,706.0 |
Federated Hermes Inc |
[2023-03-31]
|
DFND |
508,758.0 |
508,758.0 |
Versant Venture Management LLC |
[2023-03-31]
|
OTR |
0.0 |
498,558.0 |
Renaissance Technologies LLC |
[2023-03-31]
|
SOLE |
0.0 |
495,103.0 |
Morgan Stanley |
[2023-03-31]
|
DFND |
214,028.0 |
470,526.0 |
Barclays PLC |
[2023-03-31]
|
SOLE |
461,759.0 |
461,759.0 |
Walleye Trading LLC |
[2023-03-31]
|
SOLE |
450,300.0 |
450,300.0 |
Goldman Sachs Group Inc |
[2023-03-31]
|
DFND |
293,853.0 |
308,454.0 |
Allspring Global Investments Holdings, LLC |
[2023-03-31]
|
DFND |
147,558.0 |
303,779.0 |
Prev | Page 1 | Next
|
{"search": "/search", "clicked": "/clicked", "portfolio_add": "/portfolio-add", "portfolio_remove": "/portfolio-remove", "portfolio_create": "/portfolio-create", "portfolio_activate": "/portfolio-activate", "portfolio_delete": "/portfolio-delete", "portfolio_rename": "/portfolio-rename", "portfolio_color": "/portfolio-color", "home_filter": "/home-filter", "htmlspeed": "/htmlspeed", "add_tag_firm": "/add-tag-firm", "add_tag_click": "/add-tag-click", "copy_aum": "/copy-aum", "stripe_checkout": "/stripe-checkout", "update_card": "/update-card"}
{"uid": 121766817, "pid": -1, "pid_a": [], "name": "", "email": "", "blacklist_f": false, "paywall_f": false, "paywall_n": 0, "random_n": 0}
False
165443501